The Ministry of Health has initiated the centralized purchase procedure, through the National Institute of Health Management (Ingesa), of biological medicines with biosimilars for various Autonomous Communities and agencies of the General State Administration for an amount of 253.379.884,31 euros and an estimated value of the contract that amounts to a total of 370.763.164,25 euros. The tender is divided into ten lots and has an execution period of 24 months.
recently published
Horizon scanning
Jan 31 2024
Early Treatment: the role of biosimilars
18 2023 December
